1 IN 2

1 in 2 of us will be diagnosed with cancer by age 85.
Donate now

CEC Publications 1995-1999

Breast Cancer

Armes JE, Trute L, White D, Southey MC, Hammet F, Tesoriero A, Hutchins AM, Dite GS, McCredie MR, Giles GG, Hopper JL, Venter DJ. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: A population-based study. Cancer Res. 1999;59:2011-2017

Decensi A, Torrisi R, Gozza A, Severi G, Bertelli G, Fontana V, Pensa F, Carozzo L, Traverso A, Milone S, Dini D, Costa A. Effect of fenretinide on bone mineral density and metabolism in women with early breast cancer. Breast Cancer Res Treat. 1999;53:145-151

Firgaira FA, Seshadri R, McEvoy CR, Dite GS, Giles GG, McCredie MR, Southey MC, Venter DJ, Hopper JL. HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years. J Natl Cancer Inst. 1999;91:2107-2111

Harmer C, Staples M, Kavanagh AM. Evaluation of breast cancer incidence: Is the increase due entirely to mammographic screening? Cancer Causes Control. 1999;10:333-337

Hopper JL, Chenevix-Trench G, Jolley DJ, Dite GS, Jenkins MA, Venter DJ, McCredie MR, Giles GG. Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr. 1999:95-100

Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, Easton DF, Venter DJ. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol Biomarkers Prev. 1999;8:741-747

Kavanagh AM, Mitchell H, Farrugia H, Giles GG. Monitoring interval cancers in an Australian mammographic screening programme. J Med Screen. 1999;6:139-143

Southey MC, Tesoriero AA, Andersen CR, Jennings KM, Brown SM, Dite GS, Jenkins MA, Osborne RH, Maskiell JA, Porter L, Giles GG, McCredie MR, Hopper JL, Venter DJ. BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer. Br J Cancer. 1999;79:34-39

Spurdle AB, Dite GS, Chen X, Mayne CJ, Southey MC, Batten LE, Chy H, Trute L, McCredie MR, Giles GG, Armes J, Venter DJ, Hopper JL, Chenevix-Trench G. Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years. J Natl Cancer Inst. 1999;91:961-966

Tesoriero A, Andersen C, Southey M, Somers G, McKay M, Armes J, McCredie M, Giles G, Hopper JL, Venter D. De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation. Am J Hum Genet. 1999;65:567-569

Armes JE, Egan AJ, Southey MC, Dite GS, McCredie MR, Giles GG, Hopper JL, Venter DJ. The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: A population-based study. Cancer. 1998;83:2335-2345

McCredie MR, Dite GS, Giles GG, Hopper JL. Breast cancer in Australian women under the age of 40. Cancer Causes Control. 1998;9:189-198

Rodger A, Kavanagh AM. Outcome measures of an Australian breast-screening program. Med J Aust. 1998;169:179-180

Southey MC, Batten L, Andersen CR, McCredie MR, Giles GG, Dite G, Hopper JL, Venter DJ. CFTR deltaF508 carrier status, risk of breast cancer before the age of 40 and histological grading in a population-based case-control study. Int J Cancer. 1998;79:487-489

Southey MC, Batten LE, McCredie MR, Giles GG, Dite G, Hopper JL, Venter DJ. Estrogen receptor polymorphism at codon 325 and risk of breast cancer in women before age forty. J Natl Cancer Inst. 1998;90:532-536

Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet. 1995;346:995-1000

Colorectal Cancer

Kavanagh AM, Giovannucci EL, Fuchs CS, Colditz GA. Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control. 1998;9:455-462

Prostate Cancer

Boyle P, Severi G. Epidemiology of prostate cancer chemoprevention. European urology. 1999;35:370-376

Giles G, Ireland P. Diet, nutrition and prostate cancer. Int J Cancer. 1997;Suppl 10:13-17


Autier P, Dor JF, Severi G. Response: More about: Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. J Natl Cancer Inst. 1999;91:1165-1166

Autier P, Severi G, Dore JF. Betacarotene and sunscreen use. Lancet. 1999;354:2163-2164

Green A, McCredie M, MacKie R, Giles G, Young P, Morton C, Jackman L, Thursfield V. A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control. 1999;10:21-25

Burton RC, Howe C, Adamson L, Reid AL, Hersey P, Watson A, Watt G, Relic J, Holt D, Thursfield V, Clarke P, Armstrong BK. General practitioner screening for melanoma: Sensitivity, specificity, and effect of training. J Med Screen. 1998;5:156-161

Staples M, Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect? Int J Cancer. 1998;78:144-148

Czarnecki D, Staples M, Mar A, Giles G, Meehan C. Recurrent nonmelanoma skin cancer in southern Australia. Int J Dermatol. 1996;35:410-412

Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. BMJ. 1996;312:1121-1125

Green A, McCredie M, Giles G, Jackman L. Occurrence of melanomas on the upper and lower limbs in eastern Australia. Melanoma Res. 1996;6:387-394

Giles G, Staples M, McCredie M, Coates M. Multiple primary melanomas: An analysis of cancer registry data from Victoria and New South Wales. Melanoma Res. 1995;5:433-438

Other Cancer

Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, Ahlbom A, Choi WN, Giles GG, Howe GR, Little J, Menegoz F, Ryan P. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer. 1999;82:155-160

Severi G, Plesko I, Robertson C, Obsitnikova A, Boyle P. Larynx cancer in Slovakia and the role of anatomical subsites. Oral oncology. 1999;35:564-570

Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet. 1999;354:1586-1590

Altmann AE, Halliday JL, Giles GG. Associations between congenital malformations and childhood cancer. A register-based case-control study. Br J Cancer. 1998;78:1244-1249

Giles GG. The epidemiology of brain cancer. Cancer Forum. 1998:126-130

Kavanagh AM, Butler JR. The short-term financial costs of abnormal pap smears to women and government in Australia. Aust N Z J Public Health. 1998;22:347-352

Lord RV, Law MG, Ward RL, Giles GG, Thomas RJ, Thursfield V. Rising incidence of oesophageal adenocarcinoma in men in Australia. J Gastroenterol Hepatol. 1998;13:356-362

Preston-Martin S, Pogoda JM, Schlehofer B, Blettner M, Howe GR, Ryan P, Menegoz F, Giles GG, Rodvall Y, Choi NW, Little J, Arslan A. An international case-control study of adult glioma and meningioma: The role of head trauma. Int J Epidemiol. 1998;27:579-586

Cicuttini FM, Hurley SF, Forbes A, Donnan GA, Salzberg M, Giles GG, McNeil JJ. Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer. 1997;71:203-207

Giles GG. What do we know about risk factors for glioma? Cancer Causes Control. 1997;8:3-4

Kavanagh AM, Broom DH. Women's understanding of abnormal cervical smear test results: A qualitative interview study. BMJ. 1997;314:1388-1391

Mitchell H, Hirst S, Mitchell JA, Staples M, Torcello N. Effect of ethnic media on cervical cancer screening rates. Aust N Z J Public Health. 1997;21:265-267

Thompson SC, Lin A, Warren R, Giles G, Crofts N. Risk factors associated with hepatocellular carcinoma notified to the anti-cancer council of Victoria in 1991-1992. Aust N Z J Public Health. 1997;21:626-630

Giles GG. Cancer in Australia: The experience of men. Cancer Forum. 1996:117-120

McMichael AJ, Giles GG. Have increases in solar ultraviolet exposure contributed to the rise in incidence of Non-Hodgkin's Lymphoma? British J Cancer. 1996;73:945-950

Mitchell HS, Giles GG. Cancer diagnosis after a report of negative cervical cytology. Med J Aust. 1996;164:270-273

Thomas RJ, Lade S, Giles GG, Thursfield V. Incidence trends in oesophageal and proximal gastric carcinoma in Victoria. Aust N Z J Surg. 1996;66:271-275

Giles G, Waters K, Thursfield V, Farrugia H. Childhood cancer in Victoria, Australia, 1970-1989. Int J Cancer. 1995;63:794-797

Giles GG. The epidemiology of central nervous system tumours; trends and risk factors. J Clin Neurosci. 1995;2:191-205

Giles GG, Kneale BL. Vulvar cancer: The Cinderella of gynaecological oncology. Aust N Z J Obstet Gynaecol. 1995;35:71-75

Mitchell H, Medley G, Gordon I, Giles G. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: No strong evidence of benefit. Br J Cancer. 1995;71:894-897

Other Conditions

Ellis JA, Stebbing M, Harrap SB. Insulin gene polymorphism and premature male pattern baldness in the general population. Clin Sci (Lond). 1999;96:659-662

Takami S, Wong ZY, Stebbing M, Harrap SB. Linkage analysis of glucocorticoid and beta2-adrenergic receptor genes with blood pressure and body mass index. Am J Physiol. 1999;276:H1379-1384

Wong ZY, Stebbing M, Ellis JA, Lamantia A, Harrap SB. Genetic linkage of beta and gamma subunits of epithelial sodium channel to systolic blood pressure. Lancet. 1999;353:1222-1225

Zhang XH, MacMahon S, Rodgers A, Neal B. Determinants of cardiovascular disease in the Asia Pacific region: Protocol for a collaborative overview of cohort studies. CVC Prevention. 1999;4:1-19

Decensi A, Robertson C, Rotmensz N, Severi G, Maisonneuve P, Sacchini V, Boyle P, Costa A, Veronesi U. Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian chemoprevention group. Br J Cancer. 1998;78:572-578

Ellis JA, Stebbing M, Harrap SB. Genetic analysis of male pattern baldness and the 5alpha-reductase genes. J Invest Dermatol. 1998;110:849-853 http://www.ncbi.nlm.nih.gov/pubmed/9620288

Kavanagh AM, Broom DH. Embodied risk: My body, myself? Soc Sci Med. 1998;46:437-444

Stoney RM, Walker KZ, Best JD, Ireland PD, Giles GG, O'Dea K. Do postmenopausal women with NIDDM have a reduced capacity to deposit and conserve lower-body fat? Diabetes Care. 1998;21:828-830

Jenkins MA, Hopper JL, Giles GG. Regressive logistic modeling of familial aggregation for asthma in 7,394 population-based nuclear families. Genet Epidemiol. 1997;14:317-332

Hurley SF, McNeil JJ, Donnan GA, Forbes A, Salzberg M, Giles GG. Tobacco smoking and alcohol consumption as risk factors for glioma: A case-control study in Melbourne, Australia. J Epidemiol Community Health. 1996;50:442-446

Ireland PD, Giles GG. Blood pressure in the Australian- and Italian-born: A Melbourne suburb revisited after 20 years. Aust N Z J Public Health. 1996;20:143-148

Jenkins MA, Clarke JR, Carlin JB, Robertson CF, Hopper JL, Dalton MF, Holst DP, Choi K, Giles GG. Validation of questionnaire and bronchial hyperresponsiveness against respiratory physician assessment in the diagnosis of asthma. Int J Epidemiol. 1996;25:609-616

Hopper JL, Jenkins MA, Carlin JB, Giles GG. Increase in the self-reported prevalence of asthma and hay fever in adults over the last generation: A matched parent-offspring study. Aust J Public Health. 1995;19:120-124